Innovations in Diabetes Management with Food and Drinks: Key ingredients, NPD, Emerging Business Models and Leading Innovators

Date: November 1, 2010
Pages: 171
Price:
US$ 4,795.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I9A7BCBAF27EN
Leaflet:

Download PDF Leaflet

Innovations in Diabetes Management with Food and Drinks: Key ingredients, NPD, Emerging Business Models and Leading Innovators
Diabetes affects over 285 million people around the world and this it forecast to increase to 438 million by 2030. Diabetes is strongly associated with obesity; the term “diabesity” is increasingly being used by researchers in this field. Leading diabetes associations encourage the adoption of a “healthy” diet, low in saturated fats and carbohydrates and rich in fruit and vegetables to improve blood sugar control, reduce weight gain, and minimize long-term complications. In addition, low glycemic index (GI) diets may be useful in weight control, and help reduce insulin levels and insulin resistance Food, ingredient and drinks manufacturers have adopt a variety of strategies to improve the nutritious content of food and beverages in response to dietary guidelines and the rising diabetes epidemic. Whilst the first phase has targeted a reduction in salt, fat and sugar (often through the incorporation of artificial low calorie sweeteners); companies are now turning to additional nutrients and functional ingredients to promote health benefits. These include the incorporation of vitamins and mineral, modified fibers and prebiotics as well as a diverse range of phytonutrients.

This report reviews the business strategies of leading companies in the development of novel products that can improve blood glucose control and weight management. It discusses the changes in regulation and reviews health claims associated with functional ingredients and supplements. It highlights the important role of personalized nutrition in the treatment and prevention of diabetes.

Scope of this research
  • Identifies ingredient and supplements that may be beneficial in the treatment and prevention of diabetes and reviews the evidence to support claims.
  • Review market drivers regarding the uptake of “healthier” foods in blood glucose management and the personalization of nutrition.
  • Assess the impact diabetes in the emerging economies and discuss the ways in which emerging consumer may be targeted.
  • Review regulations to gain insight into the effect of these regulations on the industry in the near future.
  • Identify points of convergence of the pharma, food and drinks markets in the prevention of diabetes and the emergence of healthcare nutrition.

Research and analysis highlights

The food market is changing: Over the past decade, consumers have become more concerned for their health and wellbeing. The roll of the food and drinks industry is changing and shifting towards a more benefit driven and preventative approach.

Regulations in this competitive marketplace are evolving to encourage innovation whilst protect consumer safety. This is particularly pertinent given the gap between the regulation of supplements and that of functional ingredients.

Rising cost of product development: Companies are increasingly using a science driven approach to development new products which target diabetes. This cost time and resources and requires technical expertise. Through strategic alliances and acquisitions companies have begun to expand their product portfolios and technological capabilities.

Key reasons to purchase this research
  • Which companies and innovative products are available to diabetic consumers and what strategies and ingredients are companies adopting?
  • In what ways are companies utilising technologies to identify and validate new products which help regulate blood glucose, and to support claims?
  • What new market opportunities exist for food and drinks manufacturers to strengthen the line between food and pharma in the prevention of diabetes?
  • What the are key drivers for the emergence of healthcare nutrition and the development of personalized nutrition for diabetics, now and in the future?
  • What is the regulatory status of ingredients and supplements which target diabetes and how will changes in these regulations affect the industry?
About the author
Disclaimer
Executive summary
Introduction
Ingredients and supplements
Functional foods and drinks
Medical foods
Convergence of pharma, food & drinks in diabetes
Challenges and opportunities in the prevention and treatment of diabetes

CHAPTER 1 INTRODUCTION

Summary
Introduction
Diabetes, obesity and lifestyle changes
Diagnosis
Long term complications
Dietary impact
Prevention & treatment
Market opportunities
The Food Ingredients Sector
Fortified/functional foods
Dietary supplements
Medical foods
Pharmaceutical products
Report outline

CHAPTER 2 INGREDIENTS AND SUPPLEMENTS

Summary
Introduction
Increasing insulin secretion & insulin sensitivity
Botanicals & Natural Product Extracts
Bitter melon
Gymnema sylvestre
Heartwood
Product case study: Diabecon (The Himalaya Drug Company)
Reducing oxidative stress
Minerals & Vitamins
Minerals
Vitamins
Phytonutrients
Cinnamon
Green tea
Reducing glucose absorption
Banaba
Fenugreek
Salvia hispanica
Soy protein
Reducing inflammation
Omega 3
Reducing sugar cravings & sugar intake
Rebiana
Conclusions

CHAPTER 3 FUNCTIONAL FOOD AND DRINKS

Summary
Introduction
Artificial & natural sweeteners
Functional food & drinks
New product developments
Functional foods
Fiber enriched foods
Case Study: General Mills
Fiber-like resistant starch
Case Study: Cargill
Non-digestible prebiotic fiber
Case Study: BENEO group
Sugar free & low calorie confectionery
Case study: Mars Inc
Conclusions on functional foods
Functional drinks
Nutritional supplement drinks & shakes
Fiber enriched drinks
Protein enriched drinks
Soft drinks
Carbonated drinks
Case study: PepsiCo
Products
Research & development
Fortified waters
Case study: CocaCola
Fortified & functional fruit juices
Hot drinks
Case study: Unilever
Research
Conclusions on functional drinks
Overall conclusions

CHAPTER 4 MEDICAL FOODS

Summary
Introduction
Diabetes-specific formulas
Case Study: Abbott Nutrition
Case Study: Ajinomoto
Case Study: Groupe Danone
Case Study: Nestle
Case Study: Kalbe Nutritionals
Case Study: Victus Inc
Conclusions

CHAPTER 5 CONVERGENCE OF PHARMA, BIOTECH, FOOD AND DRINKS

Summary
Introduction
New targets for weight management & diabetes
Case Study: EGCG
Case Study: Hoodia extract
Case study: WG0401
Case study: InterMed Discovery
New targets for diabetes
Case study: Madeglucyl
Case study: Resveratrol
New targets for diabetic complications
Emerging business models
R&D constraints
Science a major driver
Predictive health status biomarkers
Application of nutrigenomics
Personalization of nutrition
Clinical assessment of new ingredients & products with health benefits
Case Study: Medicus Research
Regulatory requirements for dietary & health benefit claims
Conclusions

CHAPTER 6 CHALLENGES & OPPORTUNITIES IN THE PREVENTION & TREATMENT OF

diabetes
Summary
Introduction
Challenges
Changing regulatory environment
Changing dietary guidelines
Consumer education
Rising costs of product development
Commercial application of nutrigenomics
Opportunities
The emerging consumer
Evolution of healthcare nutrition
Targeting diabetic complications & high risk consumers
Identification of functional ingredients & foods
Market trends
Overall Conclusions

CHAPTER 7 APPENDIX

Primary research methodology
Acknowledgments
Glossary
Bibliography

TABLE OF FIGURES

Figure 1: Nutrition and Medical Nutrition Therapy (MNT)
Figure 2: Prevalence (%) estimates of diabetes (20-79) by region, 2010 and 2030
Figure 3: Impact of low and high GI foods on Blood glucose
Figure 4: Traffic light for GI foods
Figure 5: Foods most likely to be avoided by consumers in 2008 and 2010
Figure 6: Ingredients, supplements and nutrients
Figure 7: Leading oral/injectable anti diabetic drugs
Figure 8: The health and nutrition sector
Figure 9: Key US consumer health concerns, 2007
Figure 10: The role of food and pharmaceuticals in the healthcare continuum
Figure 11: Hormonal control of blood glucose
Figure 12: Reduction in blood sugar levels in type 2 diabetic patients using Diabecon
Figure 13: Cinnamon products
Figure 14: Green Tea products
Figure 15: Fenugreek products
Figure 16: Traffic Light Labelling
Figure 17: New product developments targeting diabetes, 2005-2010*
Figure 18: Diabetic Lifestyle low glycemic fiber enriched bread for diabetics
Figure 19: U.S. General Mills Uncle Sam Low GI Cereal
Figure 20: Racconto Essentials resistant starch enriched pasta suitable for diabetics
Figure 21: Snugbury prebiotic fiber enriched diabetic ice cream
Figure 22: Fiber enriched GlucoBurst diabetic drink
Figure 23: Functional soft drinks suitable for diabetics
Figure 24: Fortified water suitable for diabetics
Figure 25: Dog On It! fortified juices targeting young diabetics
Figure 26: Different types of medical food and their uses
Figure 27: Abbotts leading medical foods
Figure 28: Danone’s Diasip
Figure 29: Nestle Nutren range
Figure 30: Nestle Boost Glucose Control
Figure 31: Kalbe Nutritionals’ Diabetasol
Figure 32: Victus’ Enterex range
Figure 33: Therapeutic targets for regulation of food intake
Figure 34: R&D investment of the food and drink industry around the world
Figure 35: Scientific and technological expertise driving health nutrition
Figure 36: Nestles research and translational model: Diabetes
Figure 37: Medicus Research CRO services for Natural Product Development
Figure 38: Challenges and opportunities in the prevention of diabetes
Figure 39: Global population failing to achieve recommended intake
Figure 40: Factors influencing purchasing decisions
Figure 41: Emerging consumers
Figure 42: Emerging consumer segmentation
Figure 43: New business models driving healthcare nutrition
Figure 44: Diabetic complications

TABLE OF TABLES

Table 1: Definitions of terms relating to diabetes
Table 2: Prevention and treatment strategies for diabetes
Table 3: Ingredient profile
Table 4: Natural & Artificial Sweeteners Approved in the US
Table 5: Natural & Artificial Sweeteners Approved in the US (continued)
Table 6: Superfruits
Table 7: Superfruits (continued)
Table 8: Functional herbal teas
Table 9: Medical foods and companies
Table 10: Drivers of pharma and food and drink products
Table 11: Strategic alliances and investments in R&D technologies
Table 12: Food choices for diabetes recommended by Nutrition Subcommittee of the Diabetes
Care Advisory Committee of Diabetes UK

Ask Your Question

Innovations in Diabetes Management with Food and Drinks: Key ingredients, NPD, Emerging Business Models and Leading Innovators
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: